BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• 

  Mergers & acquisitions

  Avidity Played Hardball To Land Favorable Terms in $12B Novartis Deal

  At one point in merger negotiations with Novartis, Avidity CEO Sarah Boyce and her team walked, cutting off access to a data room and moving on to a capital raise.

  November 25, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Approvals

  Novartis Expands Spinal Muscular Atrophy Gene Therapy Market With FDA’s Itvisma Greenlight

  The FDA approved an intrathecal form of Novartis’ spinal muscular atrophy gene therapy Zolgensma on Monday, broadening access to patients two years and older in what one Stanford Medicine professor called a “game changing advance” for the field.

  November 25, 2025

   · 

  3 min read

   · 

  Heather McKenzie
• Press Releases

  Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762

  November 25, 2025

   · 

  1 min read
• Press Releases

  OS Therapies Receives Non-Proprietary Name ‘daznelimgene lisbac’ for OST-HER2 from World Health Organization

  November 25, 2025

   · 

  1 min read
• Press Releases

  MustGrow Announces Record Q3-2025 Results

  November 25, 2025

   · 

  1 min read